drug | Rhee et al. | Hou et al. | this study |
---|---|---|---|
APV | 84% | 89% | 88% |
ATV | 77% | 86% | 88% |
IDV | 79% | 86% | 93% |
LPV | 81% | 91% | 92% |
NFV | 82% | 87% | 91% |
RTV | 89% | 93% | 95% |
SQV | 84% | 89% | 89% |
3TC | 90% | * | 90% |
ABC | 77% | * | 88% |
AZT | 76% | * | 84% |
d4T | 78% | * | 84% |
ddI | 75% | * | 79% |
TDF | 73% | * | 79% |
DLV | 84% | * | 87% |
EFV | 87% | * | 88% |
NVP | 91% | * | 87% |